Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Augmenting Response to Entecavir Using a Temporary Peginterferon Alpha-2a add-on Strategy for the Treatment of HBeAg-positive Chronic Hepatitis B

NCT00877760 is registered in ClinicalTrials.gov with Foundation for Liver Research as lead sponsor.

NCT NCT00877760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00877760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Augmenting Response to Entecavir Using a Temporary Peginterferon Alpha-2a add-on Strategy for the Treatment of HBeAg-positive Chronic Hepatitis B
Lead sponsor
Foundation for Liver Research
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2009
Completion date
July 31, 2013
Enrollment
184 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b